Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis

Lung

Volumn 192, Issue 1, 2014, Pages 141-149

  Kishaba, Tomoo ^a   Tamaki, Hitoshi ^b   Shimaoka, Yousuke ^a   Fukuyama, Hajime ^a   Yamashiro, Shin ^a  

^a Okinawa Prefectural Chubu Hospital   (Japan)

^b Sunagawa Naika Clinic   (Japan)

Author keywords

Acute exacerbation; Extensive; Idiopathic pulmonary fibrosis; Limited; Staging

Indexed keywords

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREATH TESTS; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HOSPITAL MORTALITY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; LENGTH OF STAY; MALE; MIDDLE AGED; MUCIN-1; MULTIVARIATE ANALYSIS; OXYGEN; PARTIAL PRESSURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894029673     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9530-0     Document Type: Article

References (29)

1. American Thoracic Society, European Respiratory Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646-664
2. Kim DS, Collard HR, King TE Jr (2006) Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 3:285-292
3. Ley B, Collard HR, King TE Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431-440
4. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K (1993) Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 103(6):1808-1812
5. Panos RJ, Mortenson RL, Niccoli SA et al (1990) Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 88:396-404
6. Collard HR, Moore BB, Flaherty KR et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636-643
7. Song JW, Hong S-B, Lim C-M, Koh Y, Kim DS (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356-363
8. Kondoh Y, Taniguchi H, Katsuta T, Kataoka K, Kimura T, Nishiyama O, Sakamoto K, Johkoh T, Nishimura M, Ono K, Kitaichi M (2010) Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 27(2):103-110
9. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H (1992) Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 182:337-342
10. Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M, Ichikado K, Ando M, Nakamura H (1999) Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 211:555-560
11. Hansell DM, Bankier AA, Macmahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246:697-722
12. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B (2012) An Official American Thoracic Society Clinical Practice Guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185:1004-1014
13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581-586
14. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S (1997) CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 168:79-83
15. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T (2006) Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27:143-150
16. Akira M, Sakatani M, Ueda E (1993) Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 189:687-691
17. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, Inoue A, Mihara N, Honda O, Tomiyama N, Nakamura H, MuÂ̈ller ML (2008) Computed tomography findings in pathological usual interstitial pneumonia. Relationship to survival. Am J Respir Crit Care Med 177:433-439
18. Nagai S, Kitaichi M, Hamada Knagao T, Hoshino Y, Miki H, Izumi T (1999) Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. Sarcoidosis Vasc Diffuse Lung Dis 16:209-214
19. Stern J-B, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, Fournier M (2001) Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 120(1):213-219
20. Fernandez-Perez ER, Yilmaz M, Jenad H, Daniels CE, Ryu JH, Hubmayr RD, Gajic O (2008) Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 133(5):1113-1119
21. Saydain G, Islam A, Afessa B, Ryu JH, Scott JP, Peters SG (2002) Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 166:839-842
22. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM (2003) Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 167(7):962-969
23. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE Jr, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU (2011) Forced vital capacity in patients with idiopathic pulmonary fibrosis. Test properties and minimal clinically important difference. Am J Respir Crit Care Med 184:1382-1389
24. Akira M, Kozuka T, Yamamoto S, Sakatani M (2008) Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178:372-378
25. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R (2005) Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J 25:528-533
26. Parambil JG, Myers JL, Ryu JH (2005) Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 128:3310-3315
27. Kondo A, Saiki S (1989) Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H (eds) Interstitial pneumonia of unknown etiology. University of Tokyo Press, Tokyo, pp 33-42
28. Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, Yoshimura K (2005) Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. Intern Med 44:1144-1150
29. Pereira CAC, Malheiros T, Coletta EM, Ferreira RG, Rubin AS, Otta JS, Rocha NS (2006) Survival in idiopathic pulmonary fibrosis cytotoxic agents compared to corticosteroids. Respir Med 100:340-347